检索

期
标题
作者
卷 82, 编号 6 (2010)
Capacities of laboratory diagnosis in the assessment of the activity of the renin-angiotensin-aldosterone system
Maksimov M.
卷 92, 编号 10 (2020)
Dynamic changes of renin-angiotensin-aldosterone system parameters after surgery of primary hyperparathyroidism
Dobreva E., Bibik E., Eremkina A., Ajnetdinova A., Nikankina L., Malysheva N., Mokrysheva N.
PDF
(Rus)
卷 83, 编号 9 (2011)
Multicenter trial of olmesartan. Main results
Ageev F., Svirida O., Ageev F., Svirida O.
卷 78, 编号 6 (2003)
Telmisartan (micardis) - an antagonist of angiotensin II receptors of type 1: one more antihypertensivedrug or something greater?
Chazora I.
卷 92, 编号 9 (2020)
COVID-19 and cardiovascular diseases
Chazova I., Mironova O.
PDF
(Rus)
卷 83, 编号 4 (2011)
Renin-angiotensin-aldosteron system: evolution of views from renin discovery to nowadays. Perspectives of therapeutic block
Shestakova M., Shestakova M.
卷 78, 编号 1 (2003)
ACE inhibitor quinapril in the treatment of chronic cardiac failure
Gadzhiev A.
卷 90, 编号 6 (2018)
Chronic kidney disease as a multidisciplinary problem of contemporary medicine
Podzolkov V., Bragina A.
PDF
(Rus)
卷 86, 编号 6 (2014)
Effect of loop diuretics with different elimination half-lives on natriuresis changes and indicators characterizing the state of renal tubulointerstitial tissue
Arutiunov G., Dragunov D., Sokolova A.
卷 81, 编号 10 (2009)
Essential hypertension, dementia, and antihypertensive therapy in geriatric patients
Kobalava Z., Kotovskaya Y., Tyul'kina E., Kobalava Z., Kotovskaya Y., Tyulkina E.
卷 85, 编号 9 (2013)
On the way to achieve hypertension treatment goals: results of the open observational program AESCULAP (Exforge - Clinical safety and efficiency of using a double combination of antihypertensive drugs in patients with uncontrolled blood pressure)
Chazova I., Martyniuk T.
卷 81, 编号 9 (2009)
Apelin - a new protein-regulator in the cardiovascular system
Tereshchenko S., Masenko V., Cherkavskaya O., Shashkova N., Tereschenko S., Masenko V., Cherkavskaya O., Shashkova N.
卷 85, 编号 6 (2013)
General molecular and cellular mechanisms for renal and cardiac remodeling in chronic kidney disease: a target for nephrocardioprotection
Kozlovskaia L., Bobkova I., Nanchikeeva M., Chebotareva N., Li O., Plieva O.
卷 81, 编号 6 (2009)
Neurohumoral regulation of blood pressure in rheumatic patients
Shilkina N., Stolyarova S., Yunonin I., Dryazhenkova I., Shilkina N., Stolyarova S., Dryazhenkova I.
卷 85, 编号 1 (2013)
Impact of angiotensionogen and angiotensin II receptor type 1 gene polymorphisms on the development and course of chronic heart failure
Tepliakov A., Shilov S., Berezikova E., Efremov A., Safronov I., Pustovetova M., Maianskaia S., Torim I., Karpov R.
卷 81, 编号 5 (2009)
Effects of renin-angiotensin system blockers on left ventricular hypertrophy and biochemical markers of collagen balance in patients with hypertensive hypertrophy
Ovchinnikov A., Serbul V., Ageev F., Ovchinnikov A., Serbul V., Ageev F.
卷 93, 编号 3 (2021)
COVID-19 and the small intestine
Bakharev S., Baulo E., Bykova S., Dbar S., Parfenov A.
PDF
(Rus)
卷 84, 编号 6 (2012)
PHARMACOLOGICAL NEPHROPROTECTION IN CHRONIC KIDNEY DISEASE: CURRENT OPPORTUNITIES AND PERSPECTIVES (REVIEW OF FOREIGN LITERATURE)
Nikolaev A.
卷 80, 编号 6 (2008)
The role of matrix metalloproteinases in pathogenesis of renal disease
Bobkova I., Kozlovskaia L., Li O.
1 - 19 的 19 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##